FDA’s Oncology Center of Excellence published a Request for Applications for projects focused on applied regulatory science research to understand factors that affect the safety and efficacy of underrepresented populations in oncology therapeutic development.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe